STOCK MARKET REPORT by GRIMALDI & PARTNERS

MONTH REVIEW - JANUARY 2021

The international stock markets ended January with losses.

Stressful factors:

Possible delays in the planned billion-dollar US economic stimulus package.

A lack of vaccines and a sluggish vaccination campaign in Europe with simultaneous fear of the uncontrolled spread of the virus mutations.

Always new lockdowns around the globe.

The ongoing battle between private investors and falling professional hedge funds / short sellers.

At TITLE LEVEL particularly noticeable:

Sika keeps sales almost stable in the Corona year

The construction chemicals and adhesives manufacturer Sika got through the "Corona year" 2020 comparatively lightly. Not least thanks to acquisitions, sales only fell moderately. New price records were set on the stock exchange.

Sika reported sales of CHF 7.88 billion for the 2020 financial year. That is 2.9 percent less than in the previous year. The year was marked by "profound" challenges.

According to analysts, Sika has impressively demonstrated the suitability of its business model in the difficult year 2020.

MONTH OUTLOOK - FEBRUARY 2021

(...)

STOCK RECOMMENDATION OF THE MONTH

(...)

Order the full version of our stock market blog or subscribe. Simply send us your request by email to info@grimaldi-partners.ch

Thank you for your interest!